With the rapidly diversifying diagnostic industry, the In Vitro Diagnostic (IVD) has evolved as a major contributing segment. Extensive scientific research and development, technological advancements, and rising government and private sector participation are facilitating the growth globally. Demographic parameters, such as increasing disease prevalence and high disposable income have also contributed to the development of IVD services industry, which was estimated to have reached around US$ 43 Billion in 2010.

According to our new research report “Global In Vitro Diagnostic Market Analysis”, the global IVD market is likely to grow at a CAGR of around 6% during 2011-2013 to reach around US$ 52 Billion by 2013-end. The industry, which has been witnessing innovative healthcare and diagnostic solutions, is anticipated to continue striving towards technological innovation and widening its spectrum in all dimensions.

The report analyzes the key segments in the IVD market, which has witnessed tremendous growth in the recent years. The developments in the point-of-care and molecular diagnostics segment are also found to be high. The research also observes that the increasing prevalence of chronic diseases and rising technological R&D are fuelling growth in these segments. It also studies how the rising healthcare spending across the globe would impact these segments, which are likely to witness robust growth in revenues.

Our report provides a comprehensive geographic segmentation of the IVD market globally. Through top countries’ profiles, the study elaborates the performance of the IVD market in these nations, key developments in recent times, and provides forecast for the industry. The developed countries have been performing well in the IVD industry, but a great potential also lies for the industry in developing countries.

The report finds that Companion Diagnostics and Nano-diagnostics are the emerging sectors in the IVD industry, in which the growth is being fuelled by extensive R&D and novel solutions. The report also discusses the profiles of the key players in the industry to provide an insight into the competitive landscape.

Table Of Contents

1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Market Drivers
4.1 Chronic and Infectious Diseases
4.2 New Technologies
4.3 Emerging Markets
4.4 Diversifying Applications
4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2013
5.1 Point-of-Care Diagnostics
5.2 Clinical Chemistry and Immunochemistry
5.3 Molecular Diagnostics
5.4 Microbiology
5.5 Hemostasis
5.6 Hematology
5.7 Immunohematology
6. Segmentation by Indication (Current and Future Scenario - 2013)
6.1 Diabetes
6.2 Cardiovascular
6.3 Cancer
6.4 HIV
6.5 Tuberculosis
6.6 Influenza
7. Geographical Segmentation (Current and Future Scenario - 2013)
7.1 North America
7.1.1 United States
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 United Kingdom
7.2.5 Spain
7.2.6 Other European Countries
7.3 Japan
7.4 Other Key Countries
7.4.1 China
7.4.2 India
7.4.3 Turkey
7.4.4 Brazil
7.4.5 Mexico
8. Consumer Behavior Analysis
9. Emerging Sectors
9.1 Companion Diagnostics/Theranostics
9.2 Nanodiagnostics
10. Recent Developments and MandAs
11. Industry Restraints
11.1 Regulatory and Reimbursement Issues
11.2 RandD and Short Product Lifecycle
11.3 Cost Control
12. Competitive Landscape
12.1 Market Share of Top Players
12.2 Key Players
12.2.1 Roche Holding Ltd.
12.2.2 Abbott Laboratories
12.2.3 Siemens AG
12.2.4 Beckman Coulter
12.2.5 Ortho-Clinical Diagnostics

List of Figures:

Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008-2013
Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2010
Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-3: Global - Point of Care Diagnostic Market by Segment (%)
Figure 5-4: Global - Point of Care Diagnostic Market by Distribution (%)
Figure 5-5: Global - Point of Care Diagnostic Market (Billion US$), 2009-2013
Figure 5-6: Global - Clinical Chemistry and Immunochemistry Market (Billion US$), 2009-2013
Figure 5-7: Global - Share of Players in Molecular Diagnostic Market (2010)
Figure 5-8: Global - Molecular Diagnostic Market (Billion US$), 2009-2013
Figure 5-9: Global - Microbiology Diagnostic Market (Billion US$), 2010-2013
Figure 5-10: Global - Hemostasis Diagnostic Market (Billion US$), 2010-2013
Figure 5-11: Global - Hematology Market (Billion US$), 2009-2013
Figure 5-12: Global - Immunohematology Diagnostic Market (Billion US$), 2009-2013
Figure 6-1: Global - Diabetic Population (Million), 2010 and 2030
Figure 6-2: Global - Diabetes Diagnostic and Therapies Market (Billion US$), 2009-2013
Figure 6-3: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2009-2013
Figure 6-4: Global - Cancer In Vitro Diagnostic Market (Billion US$), 2011-2013
Figure 6-5: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 and 2012
Figure 6-6: Global - Tuberculosis Diagnostic Market by Segment (%)
Figure 6-7: Global - Tuberculosis Detection and Monitoring Market by Segment (%)
Figure 6-8: Global - Influenza Diagnostic Market (Million US$), 2008-2013
Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2010
Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2013
Figure 7-3: US - Labs in IVD Market by Type (%)
Figure 7-4: US - In Vitro Diagnostic Market (Billion US$), 2008-2013
Figure 7-5: Canada - In Vitro Diagnostic Market (Billion US$), 2009-2013
Figure 7-6: Europe - In Vitro Diagnostic Market (Billion Euro), 2009-2013
Figure 7-7: Europe - In Vitro Diagnostic Market by Country (%), 2009
Figure 7-8: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 7-9: Germany - In Vitro Diagnostic Market (Billion Euro), 2009-2013
Figure 7-10: France - In Vitro Diagnostic Reagents Market by Clinical Segment (%)
Figure 7-11: France - In Vitro Diagnostic Market (Billion Euro), 2009-2013
Figure 7-12: Italy - In Vitro Diagnostic Market by Segment (%), 2008
Figure 7-13: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2008
Figure 7-14: Italy - In Vitro Diagnostic Market (Billion Euro), 2009-2013
Figure 7-15: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 7-16: UK - In Vitro Diagnostic Market (Billion Euro), 2009-2013
Figure 7-17: Spain - In Vitro Diagnostic Market (Billion Euro), 2009-2013
Figure 7-18: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 7-19: Japan - Share of Players in In Vitro Diagnostic Market
Figure 7-20: Japan - In Vitro Diagnostic Market (Billion Yen), 2009-2013
Figure 7-21: China - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 7-22: China - In Vitro Diagnostic Market (Billion US$), 2009-2013
Figure 7-23: India - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 7-24: India - In Vitro Diagnostic Market (Million US$), 2009-2013
Figure 7-25: Turkey - Share of Clinical Laboratories by Type
Figure 7-26: Turkey - In Vitro Diagnostic Market (Million Euro), 2008-2013
Figure 7-27: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 7-28: Brazil - In Vitro Diagnostic Market (Million US$), 2009-2013
Figure 7-29: Mexico - In Vitro Diagnostic Market by Clinical Segment (%)
Figure 7-30: Mexico - In Vitro Diagnostic Market (Million US$), 2008-2013
Figure 11-1: Global - RandD Expenditure on IVD in Comparison to Other Industrial Sectors (%)
Figure 12-1: Global - Share of Players in In Vitro Diagnostic Market
Figure 12-2: Roche Holding Ltd. - Diagnostic Division Revenues by Segment (%), 2010
Figure 12-3: Abbott Laboratories - Diagnostic Products Sales (Million US$), 2007-2010
Figure 12-4: Siemens AG - Diagnostic Division Revenues (Million Euro), FY 2009 and FY 2010
Figure 12-5: Beckman Coulter - Clinical Diagnostics Revenues by Segment (%), 2010

List of Tables:

Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests
Table 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2010
Table 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
Table 5-3: Global - Share of Top Players in Clinical Chemistry and Immunochemistry Market (2010)
Table 5-4: Global - Share of Top Players in Microbiology Diagnostic Market (2010)
Table 5-5: Global - Share of Top Players in Hemostasis Diagnostic Market (2009)
Table 6-1: Global - Leading Companies in Diabetes Equipment Sales (Billion US$)
Table 7-1: Other European Countries - In Vitro Diagnostic Market (Million Euro), 2009
Table 12-1: Roche Holding Ltd. - Strengths and Weaknesses
Table 12-2: Abbott Laboratories - Strengths and Weaknesses
Table 12-3: Siemens AG - Strengths and Weaknesses
Table 12-4: Beckman Coulter - Strengths and Weaknesses
Table 12-5: Ortho-Clinical Diagnostics - Strengths and Weaknesses

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.